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ONE HEALTH, ONE MEDICINE

Laura H. Kahn, Thomas P. Monath, Bob H. Bokma, E. Paul Gibbs,
and A. Alonso Aguirre

In recognition that the health of humans, animals, and
the environment is linked, One Health seeks to increase
communication and collaboration across the disciplines in order to promote, improve, and defend the

health of all species on the planet. This strategy may
seem simple, but unfortunately it will not be easy to
implement. The explosion of medical knowledge in the
20th century led to academic, governmental, and
industrial silos of specialization; these silos fostered a
compartmentalized approach to health and disease.
Building bridges across these silos will require leadership, joint educational programs, financial support, and
other strategies that promote transdisciplinary efforts.
Before the 20th century, physicians typically
worked with veterinary medical colleagues and others
to improve the health of humans and animals. This
chapter will describe the historical developments in
medicine and veterinary medicine leading to the
current status quo. It will provide examples of why
the status quo is problematic and will highlight the
challenges in changing the present paradigm. It will
conclude with recommendations on how to implement a One Health approach in the future.

HISTORICAL BACKGROUND
Humans have been domesticating wild animals beginning with dogs since 14,000 years Be (Trut 1999),
developing agriculture, and altering the environment.
In contrast to the harsh nomadic hunter-gatherer
lifestyle, most humans preferred the secure and productive lifestyle that agriculture allowed. However,
this novel lifestyle introduced unanticipated health
risks since aggregated crops and concentrated livestock altered the interactions of humans, domestic
animals, wildlife, and ecosystems. Moreover, humans
lived in close proximity to animals and sometimes
shared living quarters (McNeill 1977 ).
Small farming communities eventually grew into
villages, towns, and cities, which concentrated humans
into dense living conditions that facilitated the spread
of microorganisms from individual to individual,
allowing infectious disease epidemics to develop and
propagate. As a result, infectious diseases, such as sylvatic plague, smallpox, cholera, and malaria, began to
afflict humans, leading to epidemic morbidity and
mortality (McNeill 1977 ).
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Some of the diseases affecting agricultural and
urbanized societies came from humans or livestock
after domestication, such as bovine tuberculosis, rabies,
and a wide array offood-borne bacterial and protozoan
infections as transmissible zoonoses (Diamond 1999).
In addition, wildlife served as reservoirs of innumerable diseases that could be transmitted back to humans
and domestic animals. For example, nearly one quarter
to one third of the population of Europe was decimated
by plague, also called "the Black Death" during the
mid-14th century (Wheelis 2002).
To complicate matters, people thought epidemics
were caused by divine retribution for lapsed moral
behavior, bad air "miasmas;' and demons and other
spirit beings, among other etiologies (Conrad 1992j
De Paolo 2006). These beliefs lasted for centuries,
hindering effective preventive and control efforts.
However, despite a lack of understanding of infectious
diseases, some individuals developed effective control
measures.
For example, during the 18th century, rinderpest,
a deadly viral disease of cattle, was devastating
the human food supply. Pope Clement XI asked
Dr. Giovanni Maria Lancisi, his personal physician,
to combat the problem. Lancisi recommended that
all of the ill and suspect animals be killed and buried
in lime, since he suspected that the disease was
communicable. His concept proved effective, and
in 1762, the first school of veterinary (from the
Latin "beast of burden") medicine was established in
Lyon, France, to educate the next generation about
the management of diseases in livestock (Palmarini
2007 ).

BEGINNINGS OF SClEl\"TIFIC
BREAKTHROUGHS AND ONE
HEALTH, ONE MEDICINE
In 1827, Charles Darwin decided to leave medical
school at the University of Edinburgh to pursue studies in religion and natural history at Cambridge
University. Health practitioners in Darwin's time were
routinely trained in natural history and zoology since
these disciplines were closely aligned and were considered integral subjects in medical training. Darwin
never completed medical school, but his experience
aboard the HMS Beagle, and most likely his exposure to multiple disciplines, led to his publishing his

monumental book in 1859, On the Origin of Species
(Leff 2000).
Rudolf Virchow (1821-1902), the German physician and pathologist, coined the term "zoonosis" and
said, "between animal and human medicine there are
no dividing lines-nor should there be:' He strongly
supported veterinary medicine and advocated for
public health meat inspections throughout Europe.
The United States eventually adopted meat inspections as well. This novel practice served as the basis
for modern-day public health meat and poultry
inspections by veterinarians (Kahn et aL 2007).
Sir William Osler (1849-1919), first Professor of
Medicine at Johns Hopkins Hospital and considered
the "father of modern medicine;' had traveled from
Canada to Germany to study with Virchow. Virchow
impressed upon his student the importance of autopsies, pathology, and scientific methodologies. Osler
returned to Canada to teach parasitology, physiology,
and pathology at the Montreal Veterinary College,
which eventually became affiliated with the medical
school at McGill University. At the veterinary college,
Osler researched hog cholera (classical swine fever),
Pictou cattle disease caused by tansy ragwort (Senecio
jacobaea) intoxication, which was believed to be a
microbial infection at that time, and verminous bronchitis of dogs, among others. He worked closely with
veterinarians such as Albert W Clement, who became
the President of the United States Veterinary Medical
Association (USVMAj Kahn et al. 2007).
Louis Pasteur (1822-1895) and Robert Koch (18431910) changed the course of history by discovering
that microscopic organisms caused disease. This
knowledge allowed the development of effective preventive and control measures against pathogens.
Pasteur developed a vaccine against rabies, and Koch
discovered that Clostridium tetani caused tetanus,
Streptococcus pneumoniae caused pneumonia, and
Vibrio cholerae caused cholera (Munch 2003).
The advances in scientific knowledge spurred
efforts to improve medical education. The American
Medical Association (AMA) invited the Carnegie
Foundation for the Advancement of Teaching to
conduct a study on the status of medical education in
the United States. In 1910, Abraham Flexner published
the report that recommended that medical education
be modeled after that at Johns Hopkins University,
which emphasized a scientific approach to medical
education and patient care. The ultimate effect of

One Health, One Medicine
incorporating medical schools into universities was
the emphasis on training medical specialists rather
than general practitioners (Starr 1982).
The idea of an American veterinary profession
was supported by agricultural societies and by physicians such as Benjamin Rush and Andrew Stone.
Before the 1880s, most school-trained veterinarians
were trained in Europe. The development of veterinary schools in the United States arose from concerns
over animal disease epidemics following the Civil War
and the interest in scientific agriculture signaled by
the Morrill Land Grant Act of 1862, which provided
federal funding to establish the first college-affiliated
veterinary school at Iowa State University in 1879.
The curriculum derived from agriculture and veterinary medicine. The University of Pennsylvania's
School of Veterinary Medicine opened in 1884 and
was the first accredited veterinary medical college in
the United States whose origin was in medicine rather
than agriculture.
By the late 19th century, a web of veterinary institutions, organizations, and periodicals were established,
including the USVMA, founded in 1863 and renamed
the American Veterinary MedicalAssociation (AVMA)
in 1898; the Bureau of Animal Industry (BAI), created
in 1884 in the U.S. Department ofAgriculture (USDA)
and headed until 1905 by veterinarian Daniel E.
Salmon; and the American Veterinary Review, begun in
1877 and renamed the Journal oftheAmerican Veterinary
Medical Association in 1914-1915.
BAI veterinarians Fred L. Kilbourne and Cooper
Curtice and physician Theobald Smith first demonstrated the role ofvectors in the transmission of animal
diseases. The BAI also certified and employed veterinarians in food inspection and influenced veterinary
medical school curricula. Between the 1880s and 1925,
graduate veterinarians sponsored state laws creating
examining boards and setting graduation and licensing requirements .. In late 19th and early 20th centuries,
Leonard Pearson, a bovine tuberculosis expert,
directed attention to the relationship between animal
and human health (Palmer and Waters 2011).
As the 20th century progressed, physicians became
increaSingly specialized and collaborative efforts
with veterinarians waned. Human and animal diseases
Were largely treated as separate entities. However,
a few veterinarians, such as Calvin W. Schwabe (19272006), the renowned veterinary epidemiologist and
paraSitologist, continued to promote a unified human

35

and veterinary approach to zoonotic diseases by
publishing his book Veterinary Medicine and Human
Health (Schwabe 1984).
This need to work together has not diminished
despite the professions drifting apart. Since 1940,
over 330 infectious diseases have emerged from animals into human populations (Taylor et al. 2001). The
threat to global health is increasing since human population density] the most significant independent
predictor of disease emergence, continues to increase
(Jones et al. 2008). Indeed, it is estimated that by 2050,
the human population will reach 9 billion (United
Nations 2007).
Human activities such as deforestation, intensive
agriculture, bushmeat consumption, waste production, and greenhouse gas emissions will only intensify
as growing populations demand more food, water,
clothing, shelter, and energy. For example, surveillance of fruit bat health and behavior in Malaysia
might have helped prevent the disaster that developed
in 1998-99 after extensive deforestation destroyed
the fruit bat's habitat. Millions of hectares of tropical
rain forest were slashed and burned to make way for
pig farms. Fruit bats (the natural reservoir of the
virus), whose habitat was largely destroyed by deforestation, sought nourishment from fruit trees near
the pig farms and subsequently spread the virus to
livestock. The subsequent Nipah virus outbreak demonstrates that destruction of wildlife habitats has an
adverse impact on livestock and human health. In this
case, the flowering and fruiting trees that the fruit
bats relied on for their survival were destroyed to
make room for pig farms. The bats resorted to consuming fruit located next to the farms. Pigs ate the
partially eaten fruit that had been contaminated by
bat saliva and urine. The bats harbored the Nipah
virus, a previously unknown pathogen. The economic
and human health impact of the outbreak was severe:
the pig farmers lost millions, and pig farming in the
country largely collapsed and is now allowed in only
approved areas. This set off a chain reaction that
ultimately led to the development of encephalitis in
hundreds of humans and over 100 fatalities (Kahn
2011).
The magnitude of the problem illustrates why
human medicine, veterinary medicine, and ecology
need to rejoin forces. Taylor et aI. (2001) identified
lA15 infectious agents and determined that 868 (61%)
were zoonotic. They found that zoonotic diseases
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were twice as likely to be newly emerged infections
compared to other diseases. RNA viruses, in particular, are highly likely to emerge from animals and cross
species barriers because they are subject to rapid
mutagenesis and can readily adapt to new hosts and
vectors. Examples include West Nile virus (WNV),
avian influenza virus, SARS coronavirus, arenaviruses,
and hantaviruses (Cleaveland et al. 2001).

CHALLENGES AND
OPPOHTUNITIES OF
IMPLEMENTING A NEW
PARADIGM
A new paradigm requires that human, animal, and
ecosystem health be addressed equally, equitably, and
expeditiously. Ironically, to address future threats, we
need look no further than what the medical and scientific luminaries of the 19th century developed: the
One Health concept. The One Health concept seeks
to integrate human, animal, and ecological health in
clinical practice, public health, scientific research, and
policy. Some professional organizations have recognized the importance of this paradigm. In September
2004, experts at the Wildlife Conservation Society
held a "One World, One Health" conference in New
York City that led to the "Manhattan Principles" calling for an international, interdisciplinary approach
to protect life on the planet (Cooketal. 2004). InJune
2007, the AMA House of Delegates unanimously
approved a "One Health" resolution following AVMA
input endorsing interdisciplinary collaboration with
AVMA (Kahn et al. 2008). Then AVMA approved
a similar "One Health" resolution (JAVMA, 2009).
Other organizations that have endorsed the One
Health concept include the American Society of
Tropical Medicine and Hygiene, the Society for
Tropical Veterinary Medicine, the American Society
for Microbiology, and the Council of State and
Territorial Epidemiologists.
The mission statement for the "One Health"
initiative states: "Recognizing that human and animal
health are inextricably linked, 'One Health' seeks
to promote, improve, and protect the health and
well-being of all species by enhancing cooperation
and collaboration between physicians, veterinarians,
epidemiologists, public health professionals and allied
health scientists by promoting strengths in leadership

and management to achieve these goals:' Three overarching goals are enhancing public health effectiveness, understanding anthropogenic changes and the
emergence of new pathogens of animal and human
origin, and accelerating biomedical research discoveries, including advances in clinical medical and surgical
approaches. In June 2009, the AVMA's One Health
Commission was incorporated with the mission of
developing strategies to put the One Health concept
into practice. The challenges are many, but the rewards
would be a healthier future for humans, animals, and
the Earth's ecosystems.
A similar approach was expounded by Aguirre
et al. (2002), who emphasized the need to bridge
disciplines, thereby linking human health, animal
health, and ecosystem health under the paradigm
that "health connects all species on the planef'
Conservation medicine embraces the One Health
concept by applying a transdisciplinary approach
to the study of the health relationships between
humans, animals, and ecosystems. Conservation medicine is closely allied with and primarily concentrates
on the values of conservation biology by recognizing
that health and disease are fundamentally related to
the integrity of ecosystems. Therefore, it draws on the
principles of both ecology and applied medicine in its
approach to health and disease. The international
peer-reviewed journal EcoHealth was launched in
2004 and focuses on the integration of knowledge
at the interface between ecological, human, and
veterinary health sciences and ecosystem sustainability. This publication, among others, links disciplines
and focuses attention toward "One Health, One
Medicine" (Bokma et al. 2008; Mackenzie and Jeggo
2011).

CHALLENGES AND
OPPORTUNITIES IN MEDICINE
AND VETERTNAHY MEDICINE
There are a number of challenges in implementing the
One Health concept in human and veterinary medical
education and practice. First, worldwide there are
a disproportionate number of accredited medical
schools compared to veterinary medical schools.
There are 125 accredited medical schools compared
to only 29 veterinary medical schools in the United
States, and only a handful of them share campuses.

One Health, One Medicine
Globally, there are approximately 2,161 medical schools
operating in 172 countries as of 2009. These international medical schools, recognized by their respective
governments, might not necessarily meet each other's
standards (Bokma et al. 2008; Foundation for
Advancement of International Medical Education and
Research 2009).
There are five colleges of veterinary medicine in
Canada (four fully accredited and one with limited
accreditation) and 29 in the United States (25 fully
accredited and four with limited accreditation)
fulfilling AVMA standards. In addition, the AVMA
Educational Commission for Foreign Veterinary
Graduates (ECFVG) Veterinary Schools of the World
lists 471 colleges of veterinary medicine and animal
sciences in 109 countries. The majority have either not
been evaluated by the AVMA or do not have comparable standards to meet AVMA accreditation, and only
nine (Australia [three], Scotland [two], and England,
Ireland, Netherlands, and New Zealand) fulfillAVMA
standards.
The ECFVG does not represent this as a comprehensive list of all veterinary schools in the world. For
example, Brazil has 46 veterinary colleges listed, but as
of September 2009 there are more than 108 schools,
and this may be the case for other countries. The AVMA
list includes all schools listed by the World Health
Organization in its 1991 World Veterinary Directory
and in the 1983 Pan American Health Organization
publication Diagnosis ofAnimal Health in the Americas.
The list includes additional schools that have come
to the attention of the ECFVG for reasons related to
certification.
Why would foreign medical and veterinary medical colleges want to comply with AMA or AVMA
standards? Global needs differ. For example, cattle
production and intensification have been major
concerns in developing countries. In contrast, in the
developed world, canine medicine and exotic medicine have been of primary interest. Unless international educational standards are developed, it might
be hard to convince many countries to accept U.S.
standards as a baseline.
From a purely logistical standpoint, increasing
communication and collaboration between students
of these professions would be difficult since there are
not as many schools of veterinary medicine, and of
those that exist, relatively few are close enongh to
medical schools to facilitate meaningful educational
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and collaborative efforts. During 2009, the World
Animal Health Organization ( 0 IE) released Veterinary
Education for Global Animal and Public Health (Walsh
2009), which is devoted to the improvement of
student education in global animal and public health.
The main concern expressed by this and other publications is to determine how this education can be
achieved within an already packed curriculum.
One solution might be to establish One Health
Institutes in various geographic locations globally that
would bring together medical and veterinary medical
students for cross-species disease teaching, information-sharing, and problem-solving. For example, the
Centers for Disease Control and Prevention (CDC)
established a One Health program, and two veterinary
colleges (UC-Davis and UM-Minneapolis) have
established One Health programs within their curriculum. The trend continues to grow, and these partnerships may encourage medical and veterinary medical
schools to establish "sister" institutional ties and allow
their students to spend elective time at the designated
sister school for courses not available at their home
institution.
This arrangement could facilitate building bridges
and filling gaps in areas that medical and veterinary
medical schools might not emphasize. For example,
medical schools do not emphasize public and environmental health, exotic pathogens, or the ecology of
zoonotic diseases. In contrast, veterinary medical
teaching is much more concerned with exotic pathogens (which threaten livestock if introduced), diseases
affecting multiple species, and the effects of environmental health on livestock production. The lack of
teaching of zoonoses in medical schools might explain
why physicians are generally not comfortable discussing zoonotic disease risks with their patients (Grant
and Olsen 1999).
Evidence suggests that infectious agents can
jump from animals to humans and vice versa (Childs
et al. 2007; CDC 2008). One bacterium of particular
concern is methicillin-resistant Staphylococcus aureus
(MRSA), which causes serious community-acquired
soft-tissue and skin infections (Fridkin et al. 2005), as
well as hospital-acquired infections and deaths (Klein
et al. 2007). Scott et al. (2009) found that households
with cats were almost eight times more likely to have
MRSA on one or more household surfaces than those
without cats. Members of the households in the study
did not have a history of infections or antibiotic use.
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The authors recommended that further study was
needed to determine if MRSA cross-contamination
was occurring between humans, pets, and household
surfaces. Studies assessing pathogen transmission in
home settings are critical for furthering our understanding of microbial dynamics and would help
in developing strategies to reduce disease. Since
millions of families own pets or share their homes
with animals, research to prevent the spread of pathogens in homes should be given priority, especially
since many pathogens are developing antibiotic
resistance.

CHALLENGES AND
OPPORTUNITIES iN
PUBLIC HEALTH
The WNV outbreak in New York City highlights why
disease surveillance of animals is as important as
disease surveillance in humans in protecting public
health. This outbreak illustrates that government
agencies must seamlessly integrate human and animal
disease surveillance efforts. In late May 1999, residents
in Queens, New York, noticed dead and dying birds,
and some were brought to the local veterinary clinic.
The veterinarians noted that the birds had unusual
neurological signs; unfortunately, no local or state
agency took responsibility for the large wildlife dieoff, so nothing was done to determine why these animals were dying (US. General Accounting Office
2000). A month later, an infectious disease specialist
at Flushing Hospital admitted eight patients with
encephalitis. Three patients died and CDC found
that their brain tissue contained flavivirus antigen.
These were later confirmed as the first human cases
of WNV in the Western Hemisphere (Asnis et al.
2000).

Before and concurrent with the human disease
outbreak, exotic birds at the Bronx Zoo were noted
to have died. The veterinary pathologist noted that
the birds exhibited tremors, loss of coordination, and
convulsions. Upon necropsy most birds had brain
hemorrhages and/ or meningitis similar to the human
cases. Tissues from these birds were sent to the
USAMRIID laboratories, where isolated viruses were
sent to CDC, and WNV was diagnosed by PCR and
DNA sequencing (CDC 1999). Concurrently, a group

of investigators at the University of California at Irvine
also used molecular techniques to show that the
offending agent was WNV (Briese et al. 1999). This
was the first time that the virus had appeared in
the Western Hemisphere (Mahon 2003).
In response to WNV emergence, CDC established
ArboNET, a cooperative surveillance system that
monitors the geographic spread ofWNV in mosquitoes, birds, other animals, and humans (Marfin et al.
2001). ArboNET has provided an invaluable system
for tracking the spread of WNV across the United
States and identifying early activity in mosquitoes and
birds (CDC 2008). This surveillance system demonstrates that monitoring disease activity in arthropod
vectors, animals, and humans is invaluable in tracking
zoonotic disease spread and in developing successful
containment and preventive strategies.
Unfortunately, surveillance of zoonotic diseases
on a wider scale might be more difficult to implement.
In the United States, reporting of animal diseases
varies from state to state. Some states have one agency,
typically departments of agriculture, responsible for
domestic animal disease surveillance, while others
split reporting of animal diseases between different
agencies. Wildlife on non-federal lands in the United
States is generally owned by the states. In some states,
local public health agencies are supposed to receive
reports of zoonotic diseases, primarily rabies, from
veterinarians (Kahn 2006).
At the national level, surveillance of animal health
is hindered because responsibility is split between
many different government agencies: USDA, US.
Department of Health and Senior Services, US.
Department of Interior, US. Department of Homeland Security (USDHS), and US. Department of
Commerce (National Academy of Sciences 200S).
The USDA's Animal and Plant Health Inspection
Service (APHIS) is the lead agency for livestock
health and compiles disease surveillance data that are
reportable to Food and Agriculture Organization
(FAO) and OlE. However, there is no comparable
CDC for all animals, including pets, wildlife, and zoo
animals, so there are no comprehensive data available
like in human disease surveillance.
At the federal level, one agency is primarily responsible for human health: the US. Department of Health
and Human Services (USDHS). The USDHS has
a subsidiary role in human health, and the US.
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Department of Defense provides support in times
of crisis, such as USAMRIID laboratory expertise
during the WNV crisis. State and local governments
have primary responsibility for disease surveillance in
humans, and they vary in infrastructures and capabilities (Institute of Medicine 2003). They provide
data to the CDC, which compiles the information
on a regular basis. The CDC serves primarily as a
resource for state and local health departments. The
USDA is in charge of domestic animal and captive
wildlife health; however, several agencies are responsible for wildlife, depending on the animal's status
as a migratory or non-migratory species.
Animal health and disease surveillance are also
fragmented at the international leveL WHO has
primary responsibility for human health and has a
significant presence in UN member countries. The
mission ofFAO is to promote agriculture and alleviate
hunger and offers limited animal health expertise
to member countries. The OIE has animal health
expertise, but has only a 40-person staff and no
specific country presence (Institute of Medicine
2009). The OIE's primary role is in the coordination
of information, and it has an early warning system
for member countries. It does not have the mandate
to be physically present in countries or supportive in
terms of funding. These three entities are the primary
players in global domestic animal health. Although
they work together, their different missions, functions,
and levels of support limit collaborative efforts. For
example, since the OIE is not part of the UN and has
a small staff and budget, it does not have the capacity
to assume a role analogous to WHO's role for human
health. Furthermore, none of the three has significant
staff or resources focused on wildlife or ecosystem
health.
The Institute of Medicine (2009) recognized that a
lack of comprehensive, integrated human and animal
disease surveillance systems, both in the United States
and internationally, impedes an early warning system
of emerging zoonotic diseases. International systems
need surveillance programs and diagnostic laboratory
capacities, but these are limited in developing countries, where most of the zoonotic diseases have
emerged. A centralized coordinating body would be
important in developing, harmonizing, and implementing integrated international human and animal
health surveillance activities.
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CHALLENGES AND
OPPORTUNITIES IN
ECOLOGICAL HEALTH
The importance of ecological health was illustrated
by the highly pathogenic avian influenza (HPAI)
HsNI outbreak in Hong Kong in 1997. Surveillance
of wild waterfowl and domestic poultry in southern
China during the preceding decades facilitated the
early recognition of the virus in humans (Shortridge
et al. 2003). In May 1997, HSNI was isolated in a
three-year-old boy who died of acute pneumonia
respiratory distress syndrome (ARDS) and Reye
syndrome. The isolation of this distinct avian virus
subtype from a human signaled the beginning of
a potentially deadly pandemic (deJong et al. 1997).
By December 1997, the outbreak prompted slaughtering of all poultry in Hong Kong and introducing
import control of poultry from mainland China,
supervised cleaning of poultry farms, and increased
surveillance of disease spread in humans and birds
(Tam 2002).
These actions halted the outbreak. Unfortunately,
six years later, the virus reappeared in humans in the
Fujian province of China (Writing Committee of
the WHO Consultation on Human Influenza 2005).
In Southeast Asia, HsN1outbreaks began in December
2003, devastating the poultry industries in the affected
countries (Kuiken et al. 2005; see Chapter 16 in this
volume). From 2003 to September 2009, a total of
442 laboratory-confirmed human cases were reported
from IS countries, with 262 (60%) fatalities (WHO
2009). Pathogen surveillance in wildlife was minimal
to non-existent. Kuiken et al. (2005) recommended
a joint expert working group to design and implement
a global animal surveillance system for zoonotic
pathogens. In November 2005, FAO, OIE, WHO, and
World Bank officials met to discuss the worsening
HSNI HPAI crisis and agreed that surveillance systems for human and animal influenza were critical
for effective responses. Veterinary infrastructures in
many countries needed to be assessed and strengthened to meet OIE standards, countries needed to
improve their laboratory and rapid response capabilities, and funding and investments in these efforts were
urgently needed (Jong-Wook 2005).
In 2006, two animal surveillance systems were
launched: the Global Early Warning and Response
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System for Major Animal Diseases including Zoonoses
(GLEWS) and Global Avian Influenza Network for
Surveillance (GAINS). The revised 2005 International
Health Regulations (IHR) require nations to notify
WHO, within 48 hours, of all events that might constitute a public health emergency of international
concern. WHO also has a Global Outbreak Alert and
Response Network (GOARN) that shares technical
expertise, supplies, and support to help coordinate
outbreak response investigations. Similar to the IHR
legal framework supporting WHO's central role in
collecting global public health information, the OlE's
Terrestrial Animal Health Code requires that member
countries notify OlE within 24 hours of an animal
disease event of international concern. FAO has an
early warning system, Emergency Prevention System
for Transboundary Animal Diseases (EMPRES),
established in 1994, that collects data from a variety
of sources, including from OlE, to monitor for events
of concern. The goal of GLEWS is to combine the
WHO, OlE, and FAO data collection systems into a
joint effort to facilitate communication and collaboration between human and animal health.
Unlike GLEWS, GAINS conducts active surveillance of all strains of avian influenza in wild bird
populations. Sponsored by the U.S. Agency for International Development (USAID) and the CDC,
GAINS started in 2006 and is administered by the
Wildlife Conservation Society. Dozens of partner
institutions collaborate in the GAINS network to
survey wild bird populations and collect and analyze
samples from wild birds either non-invasively or from
capture and release. All data, including denominator
data, species and sample ownership, are publicly available via a shared, open database. This early warning
system allows health officials to understand the distribution of influenza viruses as well as wild birds in
country and in neighboring countries.
Much more should be done to monitor diseases
in wildlife and domestic animals. There is no one
international governmental agency that conducts
comprehensive ecological surveillance and monitoring of diseases in animals (Karesh and Cook 2005).
Even worse, many wild animals are exported from
countries that conduct little or no surveillance of the
pathogens they might harbor (Marano et al. 2007).
In response to a monkey pox outbreak introduced
in the United States by importation of Giant Gambian
rats (Cricetomys sp.), the CDC and the U.S. Food and

Drug Administration (FDA) jointly issued an order
prohibiting the importation of Mrican rodents and
banned the sale, transport, or release of prairie dogs or
six specific genera of Mrican rodents in the United
States. The joint order was subsequently replaced by
an interim final rule, which maintains the restrictions
on African rodents, prairie dogs, and other animals.
Unfortunately, the global trade in wildlife continues
and poses serious threats to infectious disease ecology
(GLEWS 2006; Smith et al. 2009; see Chapter 11 in
this volume). There are many challenges of improving
ecological health through disease surveillance of wildlife. A One Health approach involving many parties,
including human and animal health professionals,
modelers, ecologists, sociologists, anthropologists,
and others, would help provide comprehensive, coordinated, and cohesive strategies in addressing this
immense problem.

CHALLENGES AND

OPPORTlJNITIES IN
BJOMEDlCAL RESEARCH
Society would benefit if more biomedical research
was done in comparative medicine. Comparative
medicine is not a new academic discipline: the first
chair was established in 1862 in France (Wilkinson
1992). Comparative medicine is the study of the
anatomical, physiological, pharmacological, microbiological, and pathological processes across species.
A long history of collaborations between veterinarians
and physicians has been documented. For example,
in the 20th century, Dr. RolfZinkernagel, a physician,
and Dr. Peter Doherty, a veterinarian, won the 1996
Nobel Prize in physiology or medicine for their
discovery of how normal cells are distinguished from
Virus-infected cells by a body's immune system
(Zinkernagel and Doherty 1974). These discoveries
illustrate that cross-disciplinary collaborations help
generate new scientific insights in disease.
Unfortunately, evidence suggests that the next
generations of physicians and veterinarians are not
collaborating with each other, and they are losing
interest in pursuing careers in research. From 1970 to
1997, the number of physician-scientists receiving
National Institutes of Health (NIH) grants diminished in proportion to doctoral recipients who seek
and obtain funding (Rosenberg 1999). Compared to
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the 1980s, there are now 25% fewer physician-scientists
in medical school faculties (Varki and Rosenberg
2002). To counter these trends, the NIH in 2002
established a series of competitive loan repayment
programs that provide at least two years of tax-free
debt relief for young physician-scientists committed
to clinically oriented research training. Private foundations, such as Burroughs-Wellcome and the Howard
Hughes Medical Institute, have created awards for
new physician-scientists engaged in patient-oriented
research. Some hospitals and medical schools are
creating programs to encourage medical students
to pursue research before and after receiving their
medical degrees (Ley and Rosenberg 2005).
The situation is dire for veterinarian-scientists.
A 2004 National Academy of Sciences (NAS) report
found that the total number of veterinarians who
received NIH grant support is small. In 2001, veterinarian principal investigators received only 4.7% of
all NIH grants for animal research, since the NIH does
not fund veterinary research, only research that is
of benefit to humans. An apparent consequence of
the lack of research funding available to veterinarians
is that less than 1% of AVMA members are boardcertified in laboratory animal medicine and less than
2% are board-certified in pathology (National
Research Council 2004). Much could be done to
reverse these trends. First, NIH and private foundation support for young physicians and veterinarians
interested in pursuing research careers must be
strengthened. Nowhere in the NIH's plans to improve
biomedical research in the 21st century are comparative medicine and the importance of veterinarians
mentioned, even though one of its primary goals is
to foster interdisciplinary research, encouraging new
pathways to discovery (Zerhouni 2003). The NIH
must recognize that animal health influences human
health and must be supported accordingly. Jointly
sponsored comparative medicine research grants from
the National Center for Research Resources (NCRR)
and other institutes, such as the National Institute
of Allergy and Infectious Diseases (NIAID) and the
National Cancer Institute, should be offered to medical and veterinary medical research teams to promote
collaborative efforts (National Research Council
2oosa,b). Further, some veterinary education reimbursement funding has recently been made available
by the U.S. government in the National Veterinary
Medical Service Act for veterinarians who decide to

go into government positions (http://www.avrna.
org/ advocacy/ avma_ advocate/jan09/ aa~an09b.asp
andhttp://www.avrna.org/fsvm/AnimalHealthcare%
2O(2).pdf). Also some states have begun offering veterinary student loan repayment programs (notably
Ohio; http://ovmlb.ohio.gov/sl.stm).AnewNational
Veterinary Medical Service Act will improve loan
repayment options for graduating veterinarians who
choose to work in certain areas that affect animal or
public health (http://www.avrna.org/press/releases/
100420_VMLRP.asp)

DEVELOPMENT OF NEW DRUGS
AND VACCINES BY INDUSTRY
The pharmaceutical industry provides many examples
of unnecessary separation of human and veterinary
medicine that provide impediments to progress.
Typically the animal and human health divisions of
pharmaceutical companies are physically and operationally divided. The regulatory requirements and
review of products for human and veterinary health
also lie in separate divisions of the FDA and USDA.
Since physiological and pathological underpinnings
of product development are generally shared across
species, there would be much to gain from a close
interaction between those engaged in research and
development of animal and human health products.
On the positive side, a few enlightened programs
have reached in this direction. For example, when
Akso Nobel created a new division devoted to development of human vaccines, it integrated scientists
from its veterinary health division (Intervet). Intervet
and a human vaccines biotechnology company
(Acambis) collaborated on the development of vaccines against WNv. The veterinary vaccine is now
commercially available (Prevenile") and the human
vaccine is in late stages of clinical testing. The development of these products required a close working
relationship between scientists at both companies.

THE FUTURE
The One Health concept has languished too long
in the 20th and 21st centuries in clinical care, public
and ecological health, and biomedical research.
Civilization is facing many threats, including Imman
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overpopulation, the destruction of ecosystems,
climate change, and emerging zoonotic pathogens.
The combined, synergistic creativity and insights
of transdisciplinary teams comprising physicians,
veterinarians, ecologists, public health professionals,
and others are needed to address these challenges.
The organizational, institutional, and financial
obstacles to implementing a global One Health
approach to disease threats must not be ignored. It is
incumbent upon the leaders in medicine, veterinary
medicine, science, ecology, and public health to alert
and educate political leaders, policymakers, the media,
and the public about this critical approach in global
health. Implementing a One Health approach globally
would significantly mitigate or possibly avert future
health crises.
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